Protein aggregate spreading in neurodegenerative diseases: problems and perspectives
about
The endocannabinoid system in normal and pathological brain ageingMicroRNA (miRNA): sequence and stability, viroid-like properties, and disease association in the CNSThe complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's diseaseThe preclinical phase of the pathological process underlying sporadic Alzheimer's diseaseEvolution of microRNA (miRNA) Structure and Function in Plants and Animals: Relevance to Aging and DiseaseNext-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosisTowards translational therapies for multiple system atrophyIs there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficitsMolecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.Alpha-synuclein function and dysfunction on cellular membranes.Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease.Transmission of Synucleinopathies in the Enteric Nervous System of A53T Alpha-Synuclein Transgenic MiceSpreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA.Effect of EGCG on Fe(III)-induced conformational transition of silk fibroin, a model of protein related to neurodegenerative diseases.Lysosomal Enzyme Glucocerebrosidase Protects against Aβ1-42 Oligomer-Induced Neurotoxicity.Sirt1-deficiency causes defective protein quality controlmicroRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease.Cellular and molecular biology of optineurin.Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone.Glutathione metabolism and Parkinson's disease.Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission.Replacement of huntingtin exon 1 by trans-splicing.Protein Quality Control by Molecular Chaperones in Neurodegeneration.Interaction between pathogenic proteins in neurodegenerative disorders.Examining the mechanisms that link β-amyloid and α-synuclein pathologies.Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?Understanding complexity in neurodegenerative diseases: in silico reconstruction of emergence.Integrating pathways of Parkinson's disease in a molecular interaction map.Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration.Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases.New perspectives on dietary-derived treatments and food safety-antinomy in a new era.Overexpression of cystathionine γ-lyase suppresses detrimental effects of spinocerebellar ataxia type 3.Are exosomes the vehicle for protein aggregate propagation in neurodegenerative diseases?α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process.Versatile members of the DNAJ family show Hsp70 dependent anti-aggregation activity on RING1 mutant parkin C289G.Amylin uncovered: a review on the polypeptide responsible for type II diabetes.
P2860
Q22242668-112884BE-7554-4D94-B94A-66F9D705A277Q26825514-5D798BDC-3923-49B9-A018-97877BE966E7Q26853537-83D0B023-E90D-4267-BAA7-A47BB90293A2Q28083428-BCC91667-4B30-45F5-899B-FE341C2CA242Q28647645-370BF05B-2875-4867-BAAE-8C549ADA0709Q30578913-0396C44A-4EDF-4860-BB77-9393A0C656FBQ33587948-B2C0D99A-820C-4BDF-9199-C5A98596BF27Q33797532-FE9ABBDE-FEB2-46C0-ACF8-4F36C5677F6CQ34157427-EC69C584-C74D-438E-BAF1-3153C449850BQ34430288-40F6B4C6-3F50-477B-8536-882977A239EBQ34441815-60AEF8BA-0EFD-44D5-A601-83AAF28F94E0Q34774324-EE69D324-20A7-40DD-B747-512130033564Q35070249-1AFD06EA-0AD4-48E0-BC57-9F7211C16CC2Q35707907-F721F7C2-D9AD-40B3-A040-1582FCA8AC57Q35742846-1EF729FE-6F6F-4EFA-8C02-DE7CAB0630CFQ35809943-1654E2D3-C17C-4941-A14C-6F2FD85E7F9DQ35858682-4E57E2EB-1EA5-4C4D-9255-53BFFC5A03D2Q35898247-48A415EE-7A43-4A6E-A39B-08AF2DEED88BQ36499038-FD21CA9E-0668-424C-B4B1-77486C2D29CBQ36608855-F845301A-5DF7-4607-B788-6AC9BBC845C2Q36905164-79E64D14-1400-46D2-8748-757F3E923C4EQ36918193-3CCDEBCE-85AE-4365-A4EB-D36C303790AFQ37078480-BF7324F3-DEA7-4C01-A62D-355CB96EBA1AQ37117527-70FF4B24-6DC2-404A-A69C-9322FC8E6F3BQ37418724-1FB5263E-0542-4990-9598-59532A240C3AQ37739093-3BBFDB19-EBAD-48CD-A390-12904F3B37B7Q37969262-2D85E3F6-E7FF-45D3-BDC4-1A7ACD68B3EFQ38006559-BAD10B35-8EA9-4165-80BD-F40655EC51D9Q38014888-96B0ECF8-B929-4FDC-B0F5-3DD628C88260Q38039079-C6D57924-2F5D-46AA-8482-CF3691BA9965Q38119873-C083D949-BFF2-4A72-AD5F-C023CF9D392FQ38126332-010B2CCD-ECF9-4431-916B-970D2ADDAC0EQ38182337-C4306989-98E0-43B8-A569-F96FC5BF9C37Q38219163-CB7F0A63-E1C4-4D4B-AA14-3BFE5CA24CA2Q38357564-BE2B949A-CF76-4467-A670-3C37704F0C63Q38636003-C8306686-D54D-4D44-8D78-D7BFC102D10DQ38669019-0A126AFB-907B-4A4F-B7F2-8EAD28046DBBQ39112084-9866AC35-AA0B-46EB-A29E-DAA9324E4FDBQ39314887-884B17C2-9D98-440F-8180-43E099AC121AQ39846208-96B0B69C-A9BF-4484-9220-B3F3DAFDC26F
P2860
Protein aggregate spreading in neurodegenerative diseases: problems and perspectives
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protein aggregate spreading in neurodegenerative diseases: problems and perspectives
@en
Protein aggregate spreading in neurodegenerative diseases: problems and perspectives.
@nl
type
label
Protein aggregate spreading in neurodegenerative diseases: problems and perspectives
@en
Protein aggregate spreading in neurodegenerative diseases: problems and perspectives.
@nl
prefLabel
Protein aggregate spreading in neurodegenerative diseases: problems and perspectives
@en
Protein aggregate spreading in neurodegenerative diseases: problems and perspectives.
@nl
P2093
P2860
P1476
Protein aggregate spreading in neurodegenerative diseases: problems and perspectives
@en
P2093
He-Jin Lee
Hee-Sun Lim
Seung-Jae Lee
P2860
P304
P356
10.1016/J.NEURES.2011.05.008
P577
2011-05-20T00:00:00Z